| First Author | Geng A | Year | 2020 |
| Journal | Elife | Volume | 9 |
| PubMed ID | 32749219 | Mgi Jnum | J:302396 |
| Mgi Id | MGI:6508245 | Doi | 10.7554/eLife.56434 |
| Citation | Geng A, et al. (2020) A novel function of R-spondin1 in regulating estrogen receptor expression independent of Wnt/beta-catenin signaling. Elife 9:e56434 |
| abstractText | R-spondin1 (Rspo1) has been featured as a Wnt agonist, serving as a potent niche factor for stem cells in many tissues. Here we unveil a novel role of Rspo1 in promoting estrogen receptor alpha (Esr1) expression, hence regulating the output of steroid hormone signaling in the mouse mammary gland. This action of Rspo1 relies on the receptor Lgr4 and intracellular cAMP-PKA signaling, yet is independent of Wnt/beta-catenin signaling. These mechanisms were reinforced by genetic evidence. Luminal cells-specific knockout of Rspo1 results in decreased Esr1 expression and reduced mammary side branches. In contrast, luminal cells-specific knockout of Wnt4, while attenuating basal cell Wnt/beta-catenin signaling activities, enhances Esr1 expression. Our data reveal a novel Wnt-independent role of Rspo1, in which Rspo1 acts as a bona fide GPCR activator eliciting intracellular cAMP signaling. The identification of Rspo1-ERalpha signaling axis may have a broad implication in estrogen-associated diseases. |
